Stay updated on Adjunctive Lumateperone in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Lumateperone in Major Depressive Disorder Clinical Trial page.

Latest updates to the Adjunctive Lumateperone in Major Depressive Disorder Clinical Trial page
- Check6 days agoChange DetectedThe NIH banner announcing a transition from “Artificial Intelligence” to “Super Intelligence” terminology was removed. The page continues to show a 403 error rather than the study record.SummaryDifference1%

- Check13 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2; the study record remains inaccessible behind a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedA banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” across its content.SummaryDifference1%

- Check27 days agoChange DetectedThe site footer revision label changed from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record details. The error page includes a Home link and site footer, indicating blocked access to the study information.SummaryDifference17%

Stay in the know with updates to Adjunctive Lumateperone in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Lumateperone in Major Depressive Disorder Clinical Trial page.